Market Overview The recombinant vaccines market is experiencing commercial emphasis where production scale-up, global accessibility, and market expansion drive industry growth and revenue opportunity. The recombinant vaccines market is projected to exceed USD 18.4 billion through 2030, with commercial emphasis driven by capacity demand, global health need, and financial opportunity. Commercial...